IMPLANT SCIENCES CORP
IMX
IMX was delisted on the 3rd of April, 2009.
1 hedge funds and large institutions have $12K invested in IMPLANT SCIENCES CORP in 2015 Q3 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 0 reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
57% less capital invested
Capital invested by funds: $28K → $12K (-$16K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIM
Regent Investment Management
Louisville,
Kentucky
|
-$12K |
IMX Hedge Fund Activity: Q3 2015 in Review
1 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in IMPLANT SCIENCES CORP (IMX) for Q3 2015, worth a combined $12K — down 57% from $28K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of IMX and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Regent Investment Management, exiting entirely with an estimated $12K sold.
- 1 institutional investor held IMPLANT SCIENCES CORP (IMX) as of Q3 2015, down from 2 in Q2 2015.
- Funds reported $12K of IMPLANT SCIENCES CORP stock for Q3 2015, down 57% quarter-over-quarter.
- 0 funds opened new IMPLANT SCIENCES CORP positions in Q3 2015 and 1 closed out, a net change of -1 holder.
- The largest IMPLANT SCIENCES CORP seller in Q3 2015 was Regent Investment Management, an estimated $12K sold.
Based on aggregated 13F filings for Q3 2015.